2010 Annual Scientific Meeting and Exposition 2010 Annual ...

MAY 2PostersSunday MorningPO-131: 3PO-132: 3PO-133: 3PO-134: 3PO-135: 3PO-136: 3Efficacy of Morning and Evening Dosing ofAmlodipine/Valsartan Combination in HypertensivePatients Uncontrolled by Amlodipine 5 MgRoland Asmar†, 1 Philippe Gosse, 2 Stéphane Quere, 3Assya Achouba. 3 1 Cardiovascular Medical Center,Paris, FR; 2 Saint - André Hospital, Bordeaux, FR and3 Novartis Pharma S.A.S, Rueil-Malmaison, FR.Arterial Stiffness: Impact of the Treatment withEprosartan or Enalaprilo in Mild to ModerateHypertensive Patients with Similar Peripheral BloodPressureRicardo M. Cabrera Sole, 1 Erik Luepke, 1 Juan Cañas, 2Caridad Turpin Lucas, 1 Jesualdo Masia Perez, 1 ManuelAguilera Saldaña. 1 1 University General Hospital ofAlbacete, Albacete, Albacete, ES and 2 Health Centerno 2 of Albacete, Albacete, Albacete, ES.Home BP and Clinic BP Responses in ElderlyIndividuals with Systolic Hypertension DuringInitial Treatment with Combined AngiotensinReceptor Blocker and Diuretic Compared toMonotherapy with Either ComponentW. Cushman†, 1 D. Duprez, 2 H. Weintraub, 3 R.Samuel, 4 D. Purkayastha, 4 D. Zappe, 4 J. L. Izzo, Jr. 51 Univ. Tennessee, US; 2 Univ. Minnesota, US; 3 NYUSchool of Medicine, US; 4 Novartis, US and 5 SUNYBuffalo, US.Comparison of Automated Sphygmomanometer(BPTRU) Measurements Performed in a 5 MinuteCycle with Mean Awake Ambulatory Blood PressureTarick Doleh, Marc A. Pohl, Robert Butler, Martin J.Schreiber, Jr., Mohammed A. Rafey. Cleveland ClinicFoundation, Cleveland, OH, US.Effect of Valsartan, Hydrochlorothiazide, andIts Combination on 24-Hour Ambulatory BloodPressure Response in Elderly Individuals withSystolic Hypertension: A Valvet SubstudyD. Duprez†, 1 H. Weintraub, 2 R. Samuel, 3 D.Purkayastha, 3 D. Zappe, 3 W. Cushman, 4 J. L. Izzo. 51 Univ. Minnesota, US; 2 NYU School of Medicine,US; 3 Novartis, US; 4 Univ. Tennessee, US and 5 SUNYBuffalo, US.Initiating Therapy with Intensive Dose ofCombination Amlodipine/Valsartan ProvidesImproved 24-H BP Response Compared to ModerateDose in Hypertensive Patients Uncontrolled on ARBMonotherapyThomas Giles†, 1 S. Oparil, 2 E. Ofili, 3 B. Pitt, 4 Y. Seifu, 5R. Samuel, 5 R. Hilkert, 5 J. Sowers. 6 1 Tulane Univ. SoM,US; 2 Univ. Alabama at Birmingham, US; 3 MorehouseSoM, US; 4 Univ. Michigan SoM, US; 5 Novartis, US and6 Univ. Missouri SoM, US.1 Pathobiology Track 2 Translational Track 3 Therapy Track128